World’s 1st trial deliberately infecting young adults with COVID-19 found to be safe
LONDON — The world’s first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.
The data supports the safety of this model which could theoretically provide a “plug and play” platform for testing therapies and vaccines using the original COVID-19 strain as well as variants of the virus, Open Orphan, which carried out the study, said in a statement.
Open Orphan is running the project, launched a year ago, with Imperial College London, the UK government’s vaccines task force and the clinical company hVIVO.
The trial infected 36 healthy male and female volunteers aged 18-29 years with the original SARS-CoV-2 strain of the virus and closely monitored them in a controlled quarantined setting. They will be followed up for 12 months after discharge from the quarantine facility.
No serious adverse events occurred, and the human challenge study model was shown to be safe and well tolerated in healthy young adults, the company said.
Article continues after this advertisementWith the model established, it said it should be able to contract or conduct COVID-19 human challenge studies in 2022, subject to individual ethics and regulatory approvals.
RELATED STORIES
Britain backs slew of ‘long COVID’ research studies
Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatment
Wanted: Volunteers to catch COVID in the name of science
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.